ORIGINAL RESEARCH
Published on 28 Apr 2025
Unveiling p65 as the target of diphyllin in ameliorating metabolic dysfunction-associated steatotic liver disease via targeted protein degradation technology
doi 10.3389/fphar.2025.1567639
- 497 views
- Frontiers in Pharmacology
- Translational Pharmacology
- Research Topics
- Metabolic Dysfunction-Associated Steatotic Liver Disease: From Targets to Therapeutic Strategies
Metabolic Dysfunction-Associated Steatotic Liver Disease: From Targets to Therapeutic Strategies
72
Total downloads
1,231
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.